NCT02404922View on ClinicalTrials.gov

Multiple Ascending Dose Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy
Interventions
DRUG

CTP-730

DRUG

Placebo for CTP-730

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT02404922 - Multiple Ascending Dose Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter